Dexcom (DXCM) Short-term Investments (2010 - 2017)

Dexcom (DXCM) has 8 years of Short-term Investments data on file, last reported at $107.1 million in Q4 2017.

• Quarterly Short-term Investments rose 266.78% year-over-year to $107.1 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $107.1 million (up 266.78% YoY) and the FY2017 annual result came in at $107.1 million, up 266.78% from the prior year.
• Short-term Investments retreated to $107.1 million in Q4 2017 per DXCM's latest filing, from $123.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $123.7 million in Q3 2017 and bottomed at $11.4 million in Q4 2013.
• The 5-year median for Short-term Investments is $28.0 million (2015), against an average of $35.4 million.
• The widest annual swing landed in 2013, when Short-term Investments slumped 71.92%; it then jumped 317.91% in 2017.
• Tracing DXCM's Short-term Investments over 5 years: stood at $11.4 million in 2013, then advanced by 3.51% to $11.8 million in 2014, then soared by 146.61% to $29.1 million in 2015, then advanced by 0.34% to $29.2 million in 2016, then soared by 266.78% to $107.1 million in 2017.
• Per Business Quant, the three latest DXCM Short-term Investments figures stand at $107.1 million (Q4 2017), $123.7 million (Q3 2017), and $100.7 million (Q2 2017).

Peer Comparison